A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Advanced Solid Tumors

Interventions

DRUG

ASA404

(5,6-dimethylxanthenone-4-acetic acid) DMXAA or DXAA

Trial Locations (1)

Novartis Investigative Site, Grafton, Auckland